OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Editorial Board	148
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”	132
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio	99
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles	86
Key factors governing the reconstitution time of high concentration lyophilized protein formulations	83
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study	80
Editorial Board	80
Editorial Board	75
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells	74
Rationalisation of the purification process for a phage active pharmaceutical ingredient	73
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study	73
Homogeneity and mechanical properties of orodispersible films loaded with pellets	67
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery	66
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment	65
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]	58
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody	58
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps	58
COSMO models for the pharmaceutical development of parenteral drug formulations	57
Question-based review for pharmaceutical development: An enhanced quality approach	55
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration	54
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response	51
Topical liquid formulation of bacteriophages for metered-dose spray delivery	50
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations	50
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans	43
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes	43

A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions	43
Co-axial electrosprayed RAD001-loaded polycaprolactone/polyvinyl alcohol core–shell particles for treating pediatric brain tumours	42
In silico evaluation of corneal patch eluting anti-VEGF agents concept	41
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development	40
Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study	40
Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction	40
Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway	38
Formulation strategies to provide oxygen-release to contrast local hypoxia for transplanted islets	38
Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet	37
Obtaining two polymorphic forms of paracetamol within the phase diagram with PEG 1500	36
Tacrolimus and paclitaxel co-loaded O/O ointment without surfactant: Synergistic combinations for the treatment of psoriasis	35